Make your own free website on Tripod.com

Correlation Between HHV-6 Reactivation & MS Disease Activity

Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M
J Med Virol. 2003 Jan;69(1):111-7
University of Latvia, August Kirchenstein Institute of Microbiology and Virology, Riga, Latvia
PMID# 12436486
Abstract

This study examined the association between HHV-6 infection and Multiple Sclerosis (MS) and the relationship between HHV-6 re-activation and disease activity.

The frequency of HHV-6 genomic sequences in Peripheral Blood MonoNuclear Cells (PBMCs), the incidence of plasma viremia (nPCR), the transcription of Viral mRNA in PBMCs (RT-PCR), and the presence of AntiViral IgM and IgG class AntiBodies.

In the plasma (IFA) of 16 Relapsing/Remitting and Secondary/Progressive MS patients were studied in comparison with clinical manifestations of the disease, Magnetic Resonance Imaging (MRI) of Brain, and Serum InterLeukin-12 (IL-12) concentrations (ELISA).

The prevalence of HHV-6 infection was significantly higher in patients with MS (16/26) than in patients with other Neurological diseases (6/21) and in blood donors (43/150).

HHV-6 re-activation was found during periods of disease activity with Gadolinium-enhancing lesions on MRI in both Relapsing/Remitting and Secondary/Progressive MS (10/13; 76.9%).

In patients with active MS disease, Serum concentrations of IL-12 were significantly higher in those patients with active HHV-6 infection than in patients with latent infection.

The data confirm an association between HHV-6 infection and MS and show a correlation between HHV-6 re-activation and disease activity in Relapsing/Remitting and Secondary/Progressive MS.

The risk of an exacerbation of MS was significantly higher (P < 0.005) in patients with active HHV-6 infection than in patients with latent infection.

A clear correlation between HHV-6 re-activation and Serum IL-12 concentrations during disease activity has been demonstrated. The results suggest that HHV-6 re-activation is implicated in exacerbation of MS, possibly through modulation of IL-12 synthesis.

Copyright 2003 Wiley-Liss, Inc.


Medical Texts
Anatomy | Immune System | Lymphocytes | Meds
MHC | Movement | Cranial Nerves | Physiology


MS Glossary ThJuland's MSers' Glen - Our CyberHome Page Top The Glen's Gallery: Come & Share Our Stories MS Files MS Abstracts Site Index


Abstracts
ANS | Bladder | Cognition | Fatigue | Fluid | Genetics
Interferons | IVIG | Nitric Oxide | Optic Neuritis | Pain
Physiology | Prions | Prognosis | ReMyelinate | Steroids
Stress | Treatments | TNF | Uric Acid | Viruses



Copyright 1997 - 2010:
Permission is granted to MS Societies and all MSers to utilize information from these pages provided that no financial reward is gained and attribution is given to the author/s.